Prevalence, awareness, treatment, and control of hypertension in China

Dongfeng Gu, Kristi Reynolds, Xigui Wu, Jing Chen, Xiufang Duan, Paul Muntner, Guanyong Huang, Robert F. Reynolds, Shaoyong Su, Paul K. Whelton, Jiang He

Research output: Contribution to journalArticle

454 Citations (Scopus)

Abstract

The objective of this study was to estimate the prevalence and distribution of hypertension and to determine the status of hypertension awareness, treatment, and control in the general adult population in China. The International Collaborative Study of Cardiovascular Disease in ASIA (InterASIA), conducted in 2000-2001, used a multistage cluster sampling method to select a nationally representative sample. A total of 15 540 adults, age 35 to 74 years, were examined. Three blood pressure measurements were obtained by trained observers by use of a standardized mercury sphygmomanometer after a 5-minute sitting rest. Information on history of hypertension and use of antihypertensive medications was obtained by use of a standard questionnaire. Hypertension was defined as a mean systolic blood pressure ≥140 mm Hg, diastolic blood pressure ≥90 mm Hg, and/or use of antihypertensive medications. Overall, 27.2% of the Chinese adult population age 35 to 74 years, representing 129 824 000 persons, had hypertension. The age-specific prevalence of hypertension was 17.4%, 28.2%, 40.7%, and 47.3% in men and 10.7%, 26.8%, 38.9%, and 50.2% in women age 35 to 44 years, 45 to 54 years, 55 to 64 years, and 65 to 74 years, respectively. Among hypertensive patients, only 44.7% were aware of their high blood pressure, 28.2% were taking antihypertensive medication, and 8.1% achieved blood pressure control (< 140/90 mm Hg). Our results indicate that hypertension is highly prevalent in China. The percentages of those with hypertension who are aware, treated, and controlled are unacceptably low. These results underscore the urgent need to develop national strategies to improve prevention, detection, and treatment of hypertension in China.

Original languageEnglish (US)
Pages (from-to)920-927
Number of pages8
JournalHypertension
Volume40
Issue number6
DOIs
StatePublished - Dec 1 2002
Externally publishedYes

Fingerprint

China
Hypertension
Blood Pressure
Antihypertensive Agents
Therapeutics
Sphygmomanometers
Mercury
Population
Cardiovascular Diseases

Keywords

  • China
  • Cross-sectional studies
  • Hypertension, detection and control
  • Population

ASJC Scopus subject areas

  • Internal Medicine

Cite this

Gu, D., Reynolds, K., Wu, X., Chen, J., Duan, X., Muntner, P., ... He, J. (2002). Prevalence, awareness, treatment, and control of hypertension in China. Hypertension, 40(6), 920-927. https://doi.org/10.1161/01.HYP.0000040263.94619.D5

Prevalence, awareness, treatment, and control of hypertension in China. / Gu, Dongfeng; Reynolds, Kristi; Wu, Xigui; Chen, Jing; Duan, Xiufang; Muntner, Paul; Huang, Guanyong; Reynolds, Robert F.; Su, Shaoyong; Whelton, Paul K.; He, Jiang.

In: Hypertension, Vol. 40, No. 6, 01.12.2002, p. 920-927.

Research output: Contribution to journalArticle

Gu, D, Reynolds, K, Wu, X, Chen, J, Duan, X, Muntner, P, Huang, G, Reynolds, RF, Su, S, Whelton, PK & He, J 2002, 'Prevalence, awareness, treatment, and control of hypertension in China', Hypertension, vol. 40, no. 6, pp. 920-927. https://doi.org/10.1161/01.HYP.0000040263.94619.D5
Gu, Dongfeng ; Reynolds, Kristi ; Wu, Xigui ; Chen, Jing ; Duan, Xiufang ; Muntner, Paul ; Huang, Guanyong ; Reynolds, Robert F. ; Su, Shaoyong ; Whelton, Paul K. ; He, Jiang. / Prevalence, awareness, treatment, and control of hypertension in China. In: Hypertension. 2002 ; Vol. 40, No. 6. pp. 920-927.
@article{42a8750022614564af0e11a9a748f06b,
title = "Prevalence, awareness, treatment, and control of hypertension in China",
abstract = "The objective of this study was to estimate the prevalence and distribution of hypertension and to determine the status of hypertension awareness, treatment, and control in the general adult population in China. The International Collaborative Study of Cardiovascular Disease in ASIA (InterASIA), conducted in 2000-2001, used a multistage cluster sampling method to select a nationally representative sample. A total of 15 540 adults, age 35 to 74 years, were examined. Three blood pressure measurements were obtained by trained observers by use of a standardized mercury sphygmomanometer after a 5-minute sitting rest. Information on history of hypertension and use of antihypertensive medications was obtained by use of a standard questionnaire. Hypertension was defined as a mean systolic blood pressure ≥140 mm Hg, diastolic blood pressure ≥90 mm Hg, and/or use of antihypertensive medications. Overall, 27.2{\%} of the Chinese adult population age 35 to 74 years, representing 129 824 000 persons, had hypertension. The age-specific prevalence of hypertension was 17.4{\%}, 28.2{\%}, 40.7{\%}, and 47.3{\%} in men and 10.7{\%}, 26.8{\%}, 38.9{\%}, and 50.2{\%} in women age 35 to 44 years, 45 to 54 years, 55 to 64 years, and 65 to 74 years, respectively. Among hypertensive patients, only 44.7{\%} were aware of their high blood pressure, 28.2{\%} were taking antihypertensive medication, and 8.1{\%} achieved blood pressure control (< 140/90 mm Hg). Our results indicate that hypertension is highly prevalent in China. The percentages of those with hypertension who are aware, treated, and controlled are unacceptably low. These results underscore the urgent need to develop national strategies to improve prevention, detection, and treatment of hypertension in China.",
keywords = "China, Cross-sectional studies, Hypertension, detection and control, Population",
author = "Dongfeng Gu and Kristi Reynolds and Xigui Wu and Jing Chen and Xiufang Duan and Paul Muntner and Guanyong Huang and Reynolds, {Robert F.} and Shaoyong Su and Whelton, {Paul K.} and Jiang He",
year = "2002",
month = "12",
day = "1",
doi = "10.1161/01.HYP.0000040263.94619.D5",
language = "English (US)",
volume = "40",
pages = "920--927",
journal = "Hypertension",
issn = "0194-911X",
publisher = "Lippincott Williams and Wilkins",
number = "6",

}

TY - JOUR

T1 - Prevalence, awareness, treatment, and control of hypertension in China

AU - Gu, Dongfeng

AU - Reynolds, Kristi

AU - Wu, Xigui

AU - Chen, Jing

AU - Duan, Xiufang

AU - Muntner, Paul

AU - Huang, Guanyong

AU - Reynolds, Robert F.

AU - Su, Shaoyong

AU - Whelton, Paul K.

AU - He, Jiang

PY - 2002/12/1

Y1 - 2002/12/1

N2 - The objective of this study was to estimate the prevalence and distribution of hypertension and to determine the status of hypertension awareness, treatment, and control in the general adult population in China. The International Collaborative Study of Cardiovascular Disease in ASIA (InterASIA), conducted in 2000-2001, used a multistage cluster sampling method to select a nationally representative sample. A total of 15 540 adults, age 35 to 74 years, were examined. Three blood pressure measurements were obtained by trained observers by use of a standardized mercury sphygmomanometer after a 5-minute sitting rest. Information on history of hypertension and use of antihypertensive medications was obtained by use of a standard questionnaire. Hypertension was defined as a mean systolic blood pressure ≥140 mm Hg, diastolic blood pressure ≥90 mm Hg, and/or use of antihypertensive medications. Overall, 27.2% of the Chinese adult population age 35 to 74 years, representing 129 824 000 persons, had hypertension. The age-specific prevalence of hypertension was 17.4%, 28.2%, 40.7%, and 47.3% in men and 10.7%, 26.8%, 38.9%, and 50.2% in women age 35 to 44 years, 45 to 54 years, 55 to 64 years, and 65 to 74 years, respectively. Among hypertensive patients, only 44.7% were aware of their high blood pressure, 28.2% were taking antihypertensive medication, and 8.1% achieved blood pressure control (< 140/90 mm Hg). Our results indicate that hypertension is highly prevalent in China. The percentages of those with hypertension who are aware, treated, and controlled are unacceptably low. These results underscore the urgent need to develop national strategies to improve prevention, detection, and treatment of hypertension in China.

AB - The objective of this study was to estimate the prevalence and distribution of hypertension and to determine the status of hypertension awareness, treatment, and control in the general adult population in China. The International Collaborative Study of Cardiovascular Disease in ASIA (InterASIA), conducted in 2000-2001, used a multistage cluster sampling method to select a nationally representative sample. A total of 15 540 adults, age 35 to 74 years, were examined. Three blood pressure measurements were obtained by trained observers by use of a standardized mercury sphygmomanometer after a 5-minute sitting rest. Information on history of hypertension and use of antihypertensive medications was obtained by use of a standard questionnaire. Hypertension was defined as a mean systolic blood pressure ≥140 mm Hg, diastolic blood pressure ≥90 mm Hg, and/or use of antihypertensive medications. Overall, 27.2% of the Chinese adult population age 35 to 74 years, representing 129 824 000 persons, had hypertension. The age-specific prevalence of hypertension was 17.4%, 28.2%, 40.7%, and 47.3% in men and 10.7%, 26.8%, 38.9%, and 50.2% in women age 35 to 44 years, 45 to 54 years, 55 to 64 years, and 65 to 74 years, respectively. Among hypertensive patients, only 44.7% were aware of their high blood pressure, 28.2% were taking antihypertensive medication, and 8.1% achieved blood pressure control (< 140/90 mm Hg). Our results indicate that hypertension is highly prevalent in China. The percentages of those with hypertension who are aware, treated, and controlled are unacceptably low. These results underscore the urgent need to develop national strategies to improve prevention, detection, and treatment of hypertension in China.

KW - China

KW - Cross-sectional studies

KW - Hypertension, detection and control

KW - Population

UR - http://www.scopus.com/inward/record.url?scp=0036900951&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0036900951&partnerID=8YFLogxK

U2 - 10.1161/01.HYP.0000040263.94619.D5

DO - 10.1161/01.HYP.0000040263.94619.D5

M3 - Article

C2 - 12468580

AN - SCOPUS:0036900951

VL - 40

SP - 920

EP - 927

JO - Hypertension

JF - Hypertension

SN - 0194-911X

IS - 6

ER -